OraSure Valuation Multiples

OraSure Overview

About OraSure

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Founded

2000

HQ

Employees

501

Website

orasure.com

Sectors

Medical DevicesLaboratory ServicesDeepTechHealthTech

Financials (LTM)

Revenue: $116M

EBITDA: ($39M)

EV

$32M

Valuation Multiples

Multiples.vc

Start free trial

OraSure Financials

OraSure reported last 12-month revenue of $116M and negative EBITDA of ($39M).

In the same LTM period, OraSure generated $49M in gross profit, ($39M) in EBITDA losses, and had net loss of ($65M).

OraSure P&L

In the most recent fiscal year, OraSure reported revenue of $115M and EBITDA of ($42M).

OraSure expects next 12-month revenue of XXX and NTM EBITDA of XXX

OraSure Stock Performance

OraSure has current market cap of $218M, and enterprise value of $32M.

OraSure's stock price is $3.16.

OraSure Valuation Multiples

OraSure trades at 0.3x EV/Revenue multiple, and (0.8x) EV/EBITDA.

OraSure Financial Valuation Multiples

As of April 20, 2026, OraSure has market cap of $218M and EV of $32M.

Equity research analysts estimate OraSure's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

OraSure has a P/E ratio of (3.4x).

OraSure Margins & Growth Rates

OraSure's revenue in the last 12 month grew by 4%.

OraSure's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

OraSure's rule of 40 is (26%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

OraSure's rule of X is (22%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

OraSure Public Comps

See public comps and valuation multiples for other Medical Devices and Laboratory Services comps.

OraSure M&A Activity

OraSure acquired XXX companies to date.

Last acquisition by OraSure was on XXXXXXXX, XXXXX. OraSure acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

OraSure Investment Activity

OraSure invested in XXX companies to date.

OraSure made its latest investment on XXXXXXXX, XXXXX. OraSure invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).